Analyst Coverage

Atara Biotherapeutics is covered by the following analysts.

Firm Analyst
Canaccord Genuity
John Newman, Ph.D.
Yigal Nochomovitz, Ph.D.
Cowen & Co.
Phil Nadeau, Ph.D.
Marc Frahm, Ph.D.
Goldman Sachs
Salveen Richter
Maury Raycroft, Ph.D.
J.P. Morgan
Anupam Rama
Mizuho Securities
Salim Syed
ROTH Capital Partners
Tony Butler, Ph.D.
Benjamin Burnett, Ph.D.
William Blair
Matt Phipps, Ph.D.

Atara Biotherapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Atara Biotherapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Atara Biotherapeutics or its management. Atara Biotherapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.